Literature DB >> 10644073

Tablet dissolution affected by a moisture mediated solid-state interaction between drug and disintegrant.

B R Rohrs1, T J Thamann, P Gao, D J Stelzer, M S Bergren, R S Chao.   

Abstract

PURPOSE: To investigate the cause for decrease in delavirdine mesylate 200 mg tablet dissolution upon exposure to high humidity.
METHODS: Dissolution testing was performed using the USP 2 (paddle) apparatus. Water in tablets was measured by Karl Fischer titration. 13C CP/MAS NMR was used to identify and quantify delavirdine form changes in tablets. FT-IR spectroscopy was used to monitor delavirdine form change in tablets and component mixes, and to investigate a solid state reaction with the disintegrant.
RESULTS: Dissolution extent of delavirdine mesylate 200 mg tablets was substantially decreased after exposure to high humidity. This effect is related to the amount of water present in the tablet matrix. 13C CP/ MAS NMR detected about 30% conversion from the mesylate salt of delavirdine to its free base form in the tablet matrix. FT-IR spectroscopy demonstrated that a solid state reaction occurs between the freed methanesulfonic acid and the carboxyl sites on the croscarmellose sodium disintegrant.
CONCLUSIONS: Water is thought to act as both a reaction medium and a plasticizer for croscarmellose sodium, facilitating protonation of the carboxyl sites on the disintegrant. This reaction has the potential to occur for any acid salt of a free base. The limiting solubility of delavirdine free base formed in the tablets accounts for much of the decrease in the extent of dissolution. A change in inter-particle bonding can explain the reduction in tablet deaggregation during dissolution.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10644073     DOI: 10.1023/a:1018951309506

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  7 in total

1.  Determination of the composition of delavirdine mesylate polymorph and pseudopolymorph mixtures using 13C CP/MAS NMR.

Authors:  P Gao
Journal:  Pharm Res       Date:  1996-07       Impact factor: 4.200

Review 2.  How does residual water affect the solid-state degradation of drugs in the amorphous state?

Authors:  E Y Shalaev; G Zografi
Journal:  J Pharm Sci       Date:  1996-11       Impact factor: 3.534

Review 3.  Current perspectives on the dissolution stability of solid oral dosage forms.

Authors:  K S Murthy; I Ghebre-Sellassie
Journal:  J Pharm Sci       Date:  1993-02       Impact factor: 3.534

4.  The dissolution and bioavailability of etodolac from capsules exposed to conditions of high relative humidity and temperatures.

Authors:  M Dey; R Enever; M Kraml; D G Prue; D Smith; R Weierstall
Journal:  Pharm Res       Date:  1993-09       Impact factor: 4.200

Review 5.  Cross-linking of gelatin capsules and its relevance to their in vitro-in vivo performance.

Authors:  G A Digenis; T B Gold; V P Shah
Journal:  J Pharm Sci       Date:  1994-07       Impact factor: 3.534

6.  Polymorphism in anhydrous theophylline--implications on the dissolution rate of theophylline tablets.

Authors:  N V Phadnis; R Suryanarayanan
Journal:  J Pharm Sci       Date:  1997-11       Impact factor: 3.534

7.  Solid phases of delavirdine mesylate.

Authors:  M S Bergren; R S Chao; P A Meulman; R W Sarver; M A Lyster; J L Havens; M Hawley
Journal:  J Pharm Sci       Date:  1996-08       Impact factor: 3.534

  7 in total
  14 in total

1.  Influence of drug release properties of conventional solid dosage forms on the systemic exposure of highly soluble drugs.

Authors:  L X Yu; C D Ellison; D P Conner; L J Lesko; A S Hussain
Journal:  AAPS PharmSci       Date:  2001

2.  Correlation and prediction of moisture-mediated dissolution stability for benazepril hydrochloride tablets.

Authors:  Shoufeng Li; Bill Wei; Santo Fleres; Ann Comfort; Alan Royce
Journal:  Pharm Res       Date:  2004-04       Impact factor: 4.200

Review 3.  Reactive impurities in excipients: profiling, identification and mitigation of drug-excipient incompatibility.

Authors:  Yongmei Wu; Jaquan Levons; Ajit S Narang; Krishnaswamy Raghavan; Venkatramana M Rao
Journal:  AAPS PharmSciTech       Date:  2011-09-27       Impact factor: 3.246

Review 4.  Impact of excipient interactions on solid dosage form stability.

Authors:  Ajit S Narang; Divyakant Desai; Sherif Badawy
Journal:  Pharm Res       Date:  2012-06-16       Impact factor: 4.200

5.  Salt Stability - The Effect of pHmax on Salt to Free Base Conversion.

Authors:  Yi-Ling Hsieh; Jeremy M Merritt; Weili Yu; Lynne S Taylor
Journal:  Pharm Res       Date:  2015-04-15       Impact factor: 4.200

Review 6.  The science of USP 1 and 2 dissolution: present challenges and future relevance.

Authors:  Vivian Gray; Gregg Kelly; Min Xia; Chris Butler; Saji Thomas; Stephen Mayock
Journal:  Pharm Res       Date:  2009-01-23       Impact factor: 4.200

7.  Effect of Formulation and Process Parameters on the Disproportionation of Indomethacin Sodium in Buffered Lyophilized Formulations.

Authors:  Sampada Koranne; Seema Thakral; Raj Suryanarayanan
Journal:  Pharm Res       Date:  2018-01-05       Impact factor: 4.200

8.  Implementing quality by design in pharmaceutical salt selection: a modeling approach to understanding disproportionation.

Authors:  Jeremy M Merritt; Shekhar K Viswanath; Gregory A Stephenson
Journal:  Pharm Res       Date:  2012-08-24       Impact factor: 4.200

9.  Salt stability--effect of particle size, relative humidity, temperature and composition on salt to free base conversion.

Authors:  Yi-Ling Hsieh; Lynne S Taylor
Journal:  Pharm Res       Date:  2014-08-22       Impact factor: 4.200

10.  Ionization states in the microenvironment of solid dosage forms: effect of formulation variables and processing.

Authors:  Ramprakash Govindarajan; Andrey Zinchuk; Bruno Hancock; Evgenyi Shalaev; Raj Suryanarayanan
Journal:  Pharm Res       Date:  2006-08-24       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.